Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Receives $15.77 Average Price Target from Brokerages

Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Get Free Report) has received an average recommendation of "Moderate Buy" from the ten brokerages that are presently covering the stock, MarketBeat reports. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $15.77.

SBRA has been the subject of several recent research reports. Wedbush reissued an "outperform" rating and set a $17.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, February 29th. Deutsche Bank Aktiengesellschaft assumed coverage on Sabra Health Care REIT in a research report on Tuesday, January 30th. They set a "buy" rating and a $21.00 price target on the stock.

Get Our Latest Analysis on Sabra Health Care REIT

Institutional Trading of Sabra Health Care REIT

A number of hedge funds have recently added to or reduced their stakes in SBRA. CWM LLC raised its holdings in shares of Sabra Health Care REIT by 363.5% during the third quarter. CWM LLC now owns 1,780 shares of the real estate investment trust's stock valued at $25,000 after acquiring an additional 1,396 shares during the last quarter. SG Americas Securities LLC lifted its stake in shares of Sabra Health Care REIT by 30.3% in the third quarter. SG Americas Securities LLC now owns 30,920 shares of the real estate investment trust's stock worth $431,000 after buying an additional 7,184 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Sabra Health Care REIT by 7.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 85,427 shares of the real estate investment trust's stock valued at $1,191,000 after acquiring an additional 6,032 shares in the last quarter. Caerus Investment Advisors LLC purchased a new stake in shares of Sabra Health Care REIT in the third quarter valued at approximately $214,000. Finally, Advisor Partners II LLC increased its holdings in shares of Sabra Health Care REIT by 163.8% in the third quarter. Advisor Partners II LLC now owns 119,344 shares of the real estate investment trust's stock valued at $1,664,000 after purchasing an additional 74,109 shares during the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.


Sabra Health Care REIT Price Performance

Sabra Health Care REIT stock traded up $0.13 during midday trading on Friday, reaching $14.35. 1,597,818 shares of the stock traded hands, compared to its average volume of 2,004,266. Sabra Health Care REIT has a 12 month low of $10.30 and a 12 month high of $14.91. The stock has a market cap of $3.32 billion, a P/E ratio of 287.00, a PEG ratio of 5.00 and a beta of 1.17. The stock's fifty day moving average is $14.08 and its 200-day moving average is $14.03. The company has a quick ratio of 3.41, a current ratio of 3.41 and a debt-to-equity ratio of 0.86.

Sabra Health Care REIT Company Profile

(Get Free Report

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

Featured Articles

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Should you invest $1,000 in Sabra Health Care REIT right now?

Before you consider Sabra Health Care REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.

While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Featured Articles and Offers

AMD is Down 35%. Now is the Time to Buy the Dip

AMD is Down 35%. Now is the Time to Buy the Dip

AMD stock is at a critical turning point. The market is down 7% following the release but showing some signs of support at a key level. That level aligns with the prior lows and maybe the bottom for t

Search Headlines: